Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg Gum
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Aug 14, 2017 → Jan 9, 2018
NCT ID
NCT03259607About Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg Gum
Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg Gum is a phase 1 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT03259607. Target conditions include Tobacco Dependence.
What happened to similar drugs?
7 of 10 similar drugs in Tobacco Dependence were approved
Approved (7) Terminated (3) Active (2)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03259607 | Phase 1 | Completed |
Competing Products
20 competing products in Tobacco Dependence